Two Sigma Advisers’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.1M | Sell |
|
|||||
|
2025
Q1 | $337M | Buy |
|
|||||
|
2024
Q4 | $87.9M | Buy |
|
|||||
|
2024
Q3 | $16.2M | Sell |
|
|||||
|
2024
Q2 | $22.7M | Buy |
|
|||||
|
2024
Q1 | $18M | Buy |
|
|||||
|
2023
Q4 | $14.3M | Buy |
|
|||||
|
2023
Q3 | $11.2M | Sell |
|
|||||
|
2023
Q2 | $13.6M | Buy |
|
|||||
|
2023
Q1 | $1.94M | Sell |
|
|||||
|
2022
Q4 | $2.1M | Sell |
|
|||||
|
2022
Q3 | $2.94M | Sell |
|
|||||
|
2022
Q2 | $33.6M | Sell |
|
|||||
|
2022
Q1 | $42.9M | Sell |
|
|||||
|
2021
Q4 | $75.8M | Sell |
|
|||||
|
2021
Q3 | $68.7M | Buy |
|
|||||
|
2021
Q2 | $13.5M | Buy |
|
|||||
|
2021
Q1 | $6.82M | Buy |
|
|||||
|
2020
Q4 | $2.14M | Sell |
|
|||||
|
2020
Q3 | $22.1M | Buy |
|
|||||
|
2020
Q2 | $15.7M | Buy |
|
|||||
|
2020
Q1 | $4.5M | Sell |
|
|||||
|
2019
Q4 | $8.01M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $842K | Sell |
|
|||||
|
2018
Q4 | $12.8M | Buy |
|
|||||
|
2018
Q3 | $1.31M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.76M | Sell |
|
|||||
|
2017
Q4 | $14.4M | Sell |
|
|||||
|
2017
Q3 | $23.4M | Sell |
|
|||||
|
2017
Q2 | $49.1M | Sell |
|
|||||
|
2017
Q1 | $75M | Sell |
|
|||||
|
2016
Q4 | $106M | Buy |
|
|||||
|
2016
Q3 | $11.6M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $534K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $3.42M | Buy |
|